The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Esin R.G.

Kazanskaia gosudarstvennaia meditsinskaia akademiia

Khaĭrullin I.Kh.

GBUZ "Respublikanskaia klinicheskaia bol'nitsa #2" Minzdrava Respubliki Tatarstan, Kazan'

Abrarova G.F.

Kazan Federal University, Kazan, Russia

Esin O.R.

Kazanskaia gosudarstvennaia meditsinskaia akademiia

Cerebral small vessel disease and silent cerebrovascular diseases: modern standards of diagnosis, prevention, treatment prospects

Authors:

Esin R.G., Khaĭrullin I.Kh., Abrarova G.F., Esin O.R.

More about the authors

Read: 15001 times


To cite this article:

Esin RG, Khaĭrullin IKh, Abrarova GF, Esin OR. Cerebral small vessel disease and silent cerebrovascular diseases: modern standards of diagnosis, prevention, treatment prospects. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(4):81‑87. (In Russ.)
https://doi.org/10.17116/jnevro201911904181

Recommended articles:
Difficulties in life­time diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Functional state of the kidneys in patients with various types of cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):105-111
Clinical case of auri­cular gouty tophi. Russian Bulletin of Otorhinolaryngology. 2024;(6):80-84
Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(1):109-114

References:

  1. Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease. BMJ. 2016;1(3):83-92. https://doi.org/10.1136/svn-2016-000035
  2. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. The Lancet Neurology. 2010;9(7):689-701. https://doi.org/10.1016/s1474-4422(10)70104-6
  3. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet Neurology. 2013;12(8):822-838. https://doi.org/10.1016/s1474-4422(13)70124-8
  4. Potter G, Doubal F, Jackson C, Sudlow C, Dennis M, Wardlaw J. Associations of Clinical Stroke Misclassification («Clinical-Imaging Dissociation») in Acute Ischemic Stroke. Cerebrovascular Diseases. 2010;29(4):395-402. https://doi.org/10.1159/000286342
  5. Makin SDJ, Doubal FN, Dennis MS, Wardlaw JM. Clinically Confirmed Stroke With Negative Diffusion-Weighted Imaging Magnetic Resonance Imaging. Stroke. 2015;46(11):3142-3148. https://doi.org/10.1161/strokeaha.115.010665
  6. Doubal FN, Dennis MS, Wardlaw JM. Characteristics of patients with minor ischaemic strokes and negative MRI: a cross-sectional study. Journal of Neurology, Neurosurgery & Psychiatry. 2010;82(5):540-542. https://doi.org/10.1136/jnnp.2009.190298
  7. Wardlaw JM, Doubal FN, Eadie E, Chappell F, Shuler K, Cvoro V. Little Association between Intracranial Arterial Stenosis and Lacunar Stroke. Cerebrovascular Diseases. 2011;31(1):12-18. https://doi.org/10.1159/000319773
  8. Khan A, Kasner SE, Lynn MJ, Chimowitz MI. Risk Factors and Outcome of Patients With Symptomatic Intracranial Stenosis Presenting With Lacunar Stroke. Stroke. 2012;43(5):1230-1233. https://doi.org/10.1161/strokeaha.111.641696
  9. Asdaghi N, Pearce LA, Nakajima M, Field TS, Bazan C, Cermeno F, McClure LA, Anderson DC, Hart RG, Benavente OR Clinical Correlates of Infarct Shape and Volume in Lacunar Strokes. Stroke. 2014;45(10):2952-2958. https://doi.org/10.1161/strokeaha.114.005211
  10. Del Bene A, Makin SDJ, Doubal FN, Inzitari D, Wardlaw JM. Variation in Risk Factors for Recent Small Subcortical Infarcts With Infarct Size, Shape, and Location. Stroke. 2013;44(11):3000-3006. https://doi.org/10.1161/strokeaha.113.002227
  11. Jackson CA, Hutchison A, Dennis MS, Wardlaw JM, Lindgren A, Norrving B, Anderson CS, Hankey GJ, Jamrozik K, Appelros P, Sudlow CL. Differing Risk Factor Profiles of Ischemic Stroke Subtypes. Stroke. 2010;41(4):624-629. https://doi.org/10.1161/strokeaha.109.558809
  12. Jackson C, Sudlow C. Are Lacunar Strokes Really Different? Stroke. 2005;36(4):891-901. https://doi.org/10.1161/01.str.0000157949.34986.30
  13. Smith EE, Saposnik G, Biessels GJ, Doubal FN, Fornage M, Gorelick PB, Greenberg SM, Higashida RT, Kasner SE, Seshadri S. Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017;48(2):44-71. https://doi.org/10.1161/str.0000000000000116
  14. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341(1):3666-3666. https://doi.org/10.1136/bmj.c3666
  15. Munoz DG, Hastak SM, Harper B, Lee D, Hachinski VC. Pathologic Correlates of Increased Signals of the Centrum Ovale on Magnetic Resonance Imaging. Archives of Neurology. 1993;50(5):492-497. https://doi.org/10.1001/archneur.1993.00540050044013
  16. Feigin I, Popoff N. Neuropathological changes late in cerebral edema: the relationship to trauma, hypertensive disease and Binswangerʼs encephalopathy. Journal of Neuropathology and Experimental Neurology. 1963;22(3):500-511. https://doi.org/10.1097/00005072-196307000-00011
  17. Black S, Gao F, Bilbao J. Understanding White Matter Disease: Imaging-Pathological Correlations in Vascular Cognitive Impairment. Stroke. 2008; 40(3, suppl 1):48-52. https://doi.org/10.1161/strokeaha.108.537704
  18. Maniega S, Valdés Hernández M, Clayden J, Royle N, Murray C, Morris Z, Aribisala B, Gow A, Starr J, Bastin M, Deary I., Wardlaw J. White matter hyperintensities and normal-appearing white matter integrity in the aging brain. Neurobiology of Aging. 2015;36(2):909-918. https://doi.org/10.1016/j.neurobiolaging.2014.07.048
  19. Maillard P, Fletcher E, Lockhart SN, Roach AE, Reed B, Mungas D, De Carli C, Carmichael OT. White Matter Hyperintensities and Their Penumbra Lie Along a Continuum of Injury in the Aging Brain. Stroke. 2014;45(6):1721-1726. https://doi.org/10.1161/strokeaha.113.004084
  20. Wardlaw JM, Doubal FN, Valdes-Hernandez M, Wang X, Chappell FM, Shuler K, Armitage PA, Carpenter TC, Dennis MS. Blood—Brain Barrier Permeability and Long-Term Clinical and Imaging Outcomes in Cerebral Small Vessel Disease. Stroke. 2013;44(2):525-527. https://doi.org/10.1161/strokeaha.112.669994
  21. Vermeer SE, Longstreth WT, Koudstaal PJ. Silent brain infarcts: a systematic review. The Lancet Neurology. 2007;6(7):611-619. https://doi.org/10.1016/s1474-4422(07)70170-9
  22. Braffman B, Zimmerman R, Trojanowski J, Gonatas N, Hickey W, Schlaepfer W. Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. American Journal of Roentgenology. 1988;151(3):551-558. https://doi.org/10.2214/ajr.151.3.551
  23. Potter GM, Chappell FM, Morris Z, Wardlaw JM. Cerebral Perivascular Spaces Visible on Magnetic Resonance Imaging: Development of a Qualitative Rating Scale and its Observer Reliability. Cerebrovascular Diseases. 2015;39(3-4):224-231. https://doi.org/10.1159/000375153
  24. Del C, Valdés Hernández M, Piper RJ, Wang X, Deary IJ, Wardlaw JM. Towards the automatic computational assessment of enlarged perivascular spaces on brain magnetic resonance images: A systematic review. Journal of Magnetic Resonance Imaging. 2013;38(4):774-785. https://doi.org/10.1002/jmri.24047
  25. Wuerfel J, Haertle M, Waiczies H, Tysiak E, Bechmann I, Wernecke KD, Zipp F, Paul F. Perivascular spaces — MRI marker of inflammatory activity in the brain? Brain. 2008;131(9):2332-2340. https://doi.org/10.1093/brain/awn171
  26. Shoamanesh A, Kwok CS, Benavente O. Cerebral Microbleeds: Histopathological Correlation of Neuroimaging. Cerebrovascular Diseases. 2011;32(6):528-534. https://doi.org/10.1159/000331466
  27. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, Launer LJ, Van Buchem MA, Breteler MB. Cerebral microbleeds: a guide to detection and interpretation. The Lancet Neurology. 2009;8(2):165-174. https://doi.org/10.1016/s1474-4422(09)70013-4
  28. Martinez-Ramirez S, Greenberg SM, Viswanathan A. Cerebral microbleeds: overview and implications in cognitive impairment. Alzheimer’s Research & Therapy. 2014;6(3):33. https://doi.org/10.1186/alzrt263
  29. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain. 2007;130(8):1988-2003. https://doi.org/10.1093/brain/awl387
  30. Van Dijk EJ, Breteler MMB, Schmidt R, Berger K, Nilsson L-G, Oudkerk M, Pajak A, Sans S, de Ridder M, Dufouil C, Fuhrer R, Giampaoli S, Launer LJ, Hofman A. The Association Between Blood Pressure, Hypertension, and Cerebral White Matter Lesions. Hypertension. 2004;44(5):625-630. https://doi.org/10.1161/01.hyp.0000145857.98904.20
  31. Ihara M, Yamamoto Y. Emerging Evidence for Pathogenesis of Sporadic Cerebral Small Vessel Disease. Stroke. 2016;7(2):554-560. https://doi.org/10.1161/strokeaha.115.009627
  32. Van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MMB. Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences. Stroke. 2008;39(10):2712-2719. https://doi.org/10.1161/strokeaha.107.513176
  33. Staals J, Makin SDJ, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228-1234. https://doi.org/10.1212/wnl.0000000000000837
  34. Gow AJ, Bastin ME, Munoz Maniega S, Valdes Hernandez MC, Morris Z, Murray C, Royle NA, Starr JM, Deary IJ, Wardlaw JM. Neuroprotective lifestyles and the aging brain: Activity, atrophy, and white matter integrity. Neurology. 2012;79(17):1802-1808. https://doi.org/10.1212/wnl.0b013e3182703fd2
  35. Bath PM, Wardlaw JM. Pharmacological Treatment and Prevention of Cerebral Small Vessel Disease: A Review of Potential Interventions. International Journal of Stroke. 2015;10(4):469-478. https://doi.org/10.1111/ijs.12466
  36. Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease. BMJ. 2016;1(3):83-92. https://doi.org/10.1136/svn-2016-000035
  37. Gresele P, Momi S, Falcinelli E. Anti-platelet therapy: phosphodiesterase inhibitors. British Journal of Clinical Pharmacology. 2011;72(4):634-646. https://doi.org/10.1111/j.1365-2125.2011.04034.x
  38. Feneck R. Phosphodiesterase inhibitors and the cardiovascular system. Continuing Education in Anaesthesia Critical Care & Pain. 2007;7(6):203-207. https://doi.org/10.1093/bjaceaccp/mkm039
  39. Cai Y, Knight WE, Guo S, Li J-D, Knight PA, Yan C. Vinpocetine Suppresses Pathological Vascular Remodeling by Inhibiting Vascular Smooth Muscle Cell Proliferation and Migration. Journal of Pharmacology and Experimental Therapeutics. 2012;343(2):479-488. https://doi.org/10.1124/jpet.112.195446
  40. Zhang Y, Li J, Yan C. An update on vinpocetine: New discoveries and clinical implications. European Journal of Pharmacology. 2018;819:30-34. https://doi.org/10.1016/j.ejphar.2017.11.041
  41. Zhang F, Yan C, Wei C, Yao Y, Ma X, Gong Z, Liu S, Zang D, Chen J, Shi F-D, Hao J. Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients. Translational Stroke Research. 2017;9(2):174-184. https://doi.org/10.1007/s12975-017-0549-z
  42. Sitges M, Sanchez-Tafolla BM, Chiu LM, Aldana BI, Guarneros A. Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs. Epilepsy Researc. 2011;96(3):257-266. https://doi.org/10.1016/j.eplepsyres.2011.06.006
  43. Kryzhanovsky GN. Some categories of general pathology and biology: health, disease, homeostasis, sanogenesis, adaptation, immunity. Pathophysiolog. 2004;11(3):135-138. https://doi.org/10.1016/j.pathophys.2004.08.003
  44. Tabeeva GR, Kalimeeva EYu, Koberskaya NN, Gereeva SI. Possibilities of therapy for early manifestations of chronic cerebral ischemia: results of the PROFILE program. Neurology, Neuropsychiatry, Psychosomatics. 2017;9(3):36-41. (In Russ.) https://doi.org/10.14412/2074-2711-2017-3-36-41
  45. Vakhnina NV, Milovanova OV. Neurological disorders in patients with hypertension and their correction. Neurology, Neuropsychiatry, Psychosomatics. 2016;8(4):32-37. (In Russ.) https://doi.org/10.14412/2074-2711-2016-4-32-37

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.